Sciegen Pharmaceuticals Inc recalls Gabapentin Tablets, USP 600 mg, 500 tablets per bottle, RX Only, Manufactured by ScieGen Pharmaceuticals Inc., Hauppaug…

Recall date

February 17, 2023

Source

U.S. Food & Drug Administration (FDA) — enforcement report

Recall number

D-0354-2023

FDA classification

Class III

Brand / firm

Sciegen Pharmaceuticals Inc

Sold / distributed

Nationwide in the USA and Puerto Rico

Why it was recalled

Presence of Foreign Tablets/Capsules: Pharmacist reported presence of some Gabapentin tablets 800 mg comingled in Gabapentin 600 mg 500 count bottles.

Class III means the product violates regulations but is not likely to cause harm.

What was recalled

Gabapentin Tablets, USP 600 mg, 500 tablets per bottle, RX Only, Manufactured by ScieGen Pharmaceuticals Inc., Hauppauge, NY 11788, NDC: 50228-177-05.